These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 2883798
21. Acetylcholine stimulates insulin, glucagon, and somatostatin release in the perfused chicken pancreas. Honey RN, Weir GC. Endocrinology; 1980 Oct; 107(4):1065-8. PubMed ID: 6105951 [Abstract] [Full Text] [Related]
22. Effects of growth hormone-releasing hormone on the secretion of islet hormones and on glucose homeostasis in lean and genetically obese-diabetic (ob/ob) mice and normal rats. Bailey CJ, Wilkes LC, Flatt PR, Conlon JM, Buchanan KD. J Endocrinol; 1989 Oct; 123(1):19-24. PubMed ID: 2572664 [Abstract] [Full Text] [Related]
23. Effect of nerve blockade on pulsatile insulin and glucagon secretion in vitro. Opara EC, Go VL. Pancreas; 1991 Nov; 6(6):653-8. PubMed ID: 1780325 [Abstract] [Full Text] [Related]
24. Effect of electrical field stimulation on insulin and glucagon secretion from the pancreas of normal and diabetic rats. Adeghate E, Ponery AS, Wahab A. Horm Metab Res; 2001 May; 33(5):281-9. PubMed ID: 11440274 [Abstract] [Full Text] [Related]
25. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA, Cryer PE, Gerich JE. J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [Abstract] [Full Text] [Related]
27. The role of the autonomic nervous system in mediating pancreatic endocrine responses to arginine in the calf. Edwards AV, Bloom SR. Experientia; 1986 Feb 15; 42(2):158-60. PubMed ID: 3512287 [Abstract] [Full Text] [Related]
28. Role of intrapancreatic ganglia in regulation of periodic insular secretions. Stagner JI, Samols E. Am J Physiol; 1985 May 15; 248(5 Pt 1):E522-30. PubMed ID: 3887940 [Abstract] [Full Text] [Related]
29. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Iversen J. J Clin Invest; 1973 Sep 15; 52(9):2102-16. PubMed ID: 4727451 [Abstract] [Full Text] [Related]
32. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Hermansen K. Endocrinology; 1983 Sep 15; 113(3):1149-54. PubMed ID: 6135603 [Abstract] [Full Text] [Related]
33. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin. Aguila MC, McCann SM. Endocrinology; 1987 Jan 15; 120(1):341-4. PubMed ID: 2877865 [Abstract] [Full Text] [Related]
34. Nervous control of pancreatic endocrine secretion in pigs. II. The effect of pharmacological blocking agents on the response to vagal stimulation. Holst JJ, Grønholt R, Schaffalitzky de Muckadell OB, Fahrenkrug J. Acta Physiol Scand; 1981 Jan 15; 111(1):9-14. PubMed ID: 6111894 [Abstract] [Full Text] [Related]
35. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas. Hermansen K, Ahrén B. Acta Physiol Scand; 1990 Feb 15; 138(2):175-9. PubMed ID: 1969219 [Abstract] [Full Text] [Related]
36. Certain pharmacological characteristics of the release of pancreatic glucagon in response to stimulation of the splanchnic nerves. Bloom SR, Edwards AV. J Physiol; 1978 Jul 15; 280():25-35. PubMed ID: 690873 [Abstract] [Full Text] [Related]
37. Effects of PACAP(1-27) on the canine endocrine pancreas in vivo: interaction with cholinergic mechanism. Yamaguchi N, Minassian TR, Yamaguchi S. Can J Physiol Pharmacol; 2003 Jul 15; 81(7):720-9. PubMed ID: 12897820 [Abstract] [Full Text] [Related]
38. Adrenergic modulation of pancreatic glucagon and insulin secretion in goats. Oda S, Ohtomo Y, Ohneda A, Sasaki Y, Tsuda T. Comp Biochem Physiol A Comp Physiol; 1986 Jul 15; 84(4):723-8. PubMed ID: 2875840 [Abstract] [Full Text] [Related]
39. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M. J Clin Invest; 1971 May 15; 50(5):1069-79. PubMed ID: 4928263 [Abstract] [Full Text] [Related]
40. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism. Cyrus J, Stagner J, Samols E. Endocrinology; 1982 Jul 15; 111(1):214-8. PubMed ID: 6123430 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]